Table 2 Log-fold changes in cytokine levels by disease group compared to control.
Cytokine | Disease | Log-fold Estimate | 2.5 Percentile | 97.5 Percentile | Holm’s p-value | Post Hoc Power | Effect Size \({{\varvec{\eta}}}_{{\varvec{p}}}^{2}\) 95% CI |
|---|---|---|---|---|---|---|---|
ADAMTS13 | IPF | 0.090 | − 0.237 | 0.418 | 0.0363 | 0.9998 | 0.22 |
dcSSc ILD | − 0.026 | − 0.536 | 0.014 | (0.09, 0.63) | |||
dcSSc NoILD | − 0.068 | − 0.360 | 0.224 | ||||
lcSSc ILD | − 0.400 | − 0.124 | 0.150 | ||||
lcSSc NoILD | − 0.383 | − 0.662 | − 0.104 | ||||
Eotaxin-1 | IPF | 0.753 | 0.185 | 1.321 | 0.0011 | 0.9999 | 0.28 |
dcSSc ILD | 1.088 | 0.610 | 1.566 | (0.13, 0.70) | |||
dcSSc NoILD | 0.829 | 0.320 | 1.338 | ||||
lcSSc ILD | 0.805 | 0.330 | 1.281 | ||||
lcSSc NoILD | 0.617 | 0.133 | 1.101 | ||||
IL-6 | IPF | 1.879 | 0.398 | 3.359 | 0.0072 | 0.9998 | 0.25 |
dcSSc ILD | 2.259 | 1.013 | 3.505 | (0.11, 0.67) | |||
dcSSc NoILD | 0.937 | − 0.390 | 2.263 | ||||
lcSSc ILD | 1.977 | 0.738 | 3.217 | ||||
lcSSc NoILD | 0.349 | − 0.913 | 1.610 | ||||
MIG/CXCL9 | IPF | 0.468 | − 0.298 | 1.233 | 0.0368 | 0.9838 | 0.22 |
dcSSc ILD | 0.524 | − 0.120 | 1.168 | (0.09, 0.63) | |||
dcSSc NoILD | 0.264 | − 0.421 | 0.950 | ||||
lcSSc ILD | 1.056 | 0.415 | 1.696 | ||||
lcSSc NoILD | 0.707 | 0.055 | 1.359 |